Bliss GVS Pharma Ltd. Logo

Bliss GVS Pharma Ltd. (BLISSGVS)

NSE

Currency in INR
639.35
-9.30 (-1.43%)

Closed

Sep 3, 2026

Day's Range

635.00
665.00

52 wk Range

118.00
665.00

Profile - BLISSGVS - Bliss GVS Pharma Ltd.

Profile

Mic Code

XNSE

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

966


Bliss GVS Pharma Ltd. is a pharmaceutical company that specializes in the research, development, manufacturing, and marketing of pharmaceutical products. The primary focus of the company is to offer affordable and effective healthcare solutions through its extensive range of products, which include anti-malarial, antibacterial, antifungal, anti-inflammatory, gynecological, and wellness products. Bliss GVS Pharma serves a wide array of healthcare segments, aiming to deliver comprehensive treatments across diverse therapeutic domains. The company is notably active in emerging markets, which are critical in expanding its geographical footprint and ensuring access to essential medicines. Bliss GVS Pharma is committed to quality and innovation, leveraging advanced research and development capabilities to enhance its product offerings. In the financial market, Bliss GVS Pharma holds significance due to its strong presence in the global pharmaceutical industry and its ongoing efforts to address both common and complex medical needs. The company's approach to fostering healthcare accessibility aligns with broader global health initiatives, reinforcing its role in the pharmaceutical industry as a versatile and adaptive entity.

Profile Details

Type

Common Stock

Ceo

Mr. Shibroor Narsimha Kamath

Address

102, Hyde Park

City

Mumbai

Zip

400072

Country

India

Phone

91 22 4216 0000

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.